Which medication is contraindicated in patients with asthma for treating postpartum hemorrhage?

• A. Oxytocin
• B. Carboprost (Hemabate)
• C. Methylergonovine (Methergine)
• D. Misoprostol (Cytotec)

Answer: (B)

Carboprost (Hemabate) is contraindicated in patients with asthma due to its potential to cause bronchoconstriction. This medication is a prostaglandin analogue that can stimulate smooth muscle contraction, and in individuals with asthma, this action can exacerbate respiratory symptoms and lead to severe bronchospasm.

In contrast, the other medications listed are generally considered safer options for treating postpartum hemorrhage in asthmatic patients. Oxytocin, for example, is commonly used to promote uterine contractions and does not have significant respiratory side effects. Methylergonovine can also be used cautiously, although it is usually not preferred in cases where hypertension is a concern. Misoprostol is often used for its uterotonic properties and can be administered rectally or orally, providing flexibility in administration without the risk of bronchial constriction associated with Carboprost.

Thus, understanding the specific reactions and contraindications of Carboprost is crucial for safely managing postpartum hemorrhage, especially in patients with underlying respiratory conditions like asthma.